William F. Doyle - Aug 2, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Executive Chairman, Director
Signature: By: /s/ Kimberly Burke, Attorney in fact for William F. Doyle
Stock symbol: NVCR
Transactions as of: Aug 2, 2021
Transactions value $: -$148,631
Form type: 4
Date filed: 8/4/2021, 05:01 PM
Previous filing: Jun 15, 2021
Next filing: Dec 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	-$149K	-995	-0.18%	$149.38^*	554K	Aug 2, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.